Viewing Study NCT07106034


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-01-06 @ 9:52 PM
Study NCT ID: NCT07106034
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-12
First Post: 2025-07-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
Sponsor: Shanghai Pudong Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module